Now Available: Spotlight on Alamar Biosciences CEO Yuling Luo. Click here to read.
RedShiftBio has created a platform that combines microfluidic modulation spectroscopy (MMS) and quantum cascade lasers to generate precise, ultra-sensitive molecular structure measurements. “We are helping our customers see things they simply could not see before because it was too challenging or they didn't have the sensitivity or resolution,” said CEO Julien Bradley. “This technology opens ...
“Fluent’s technology eliminates the need for complex, expensive instrumentation and microfluidic consumables,” said Wouter Meuleman, Partner at Illumina Ventures. “PIPseq is a simple, scalable workflow that can enable single cell sequencing in every lab for many applications while reducing costs and increasing accessibility.”
"This idea that we could infuse these long-lasting, therapeutic protein factories into patients captured our imagination,” said Alexis Ji, Venture Partner at Illumina Ventures. “Rather than patients going to the clinic over and over, the treatment is always there. This creates the potential to offer functional cures for serious diseases.”
"This is an exciting direction because it offers opportunities for actual cures," said Illumina Ventures partner Wouter Meuleman. "The ability to correct single-nucleotide variations, or even replace entire genes, will change how we practice medicine."
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
